American Century Companies Inc Ginkgo Bioworks Holdings, Inc. Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $95,260 - $150,286	59,168 Added 56.82%	163,298 $295,000
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $280 - $479	-246 Reduced 0.24%	104,130 $193,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $81,268 - $175,500	49,858 Added 91.45%	104,376 $176,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $31,852 - $163,191	43,634 Added 400.9%	54,518 $170,000
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $23,944 - $45,712	10,884 New	10,884 $26,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.